ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 ,inter alia, to consider and approve This is to inform that the Meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Friday, February 10, 2023 inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. We would also like to inform you that the 'Trading Window' remains closed for all Designated Persons, from December 16, 2022 to February 12, 2023 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015. We request you to please take the same on record.